Skip to main content
An official website of the United States government

A Behaviorally-Based Tailored Disease Management Intervention to Prevent Liver Cancer in Patients with Risk Factors for Liver Disease

Trial Status: closed to accrual

This clinical trial tests whether a behaviorally-based tailored disease management intervention works to prevent liver cancer in patients with liver fibrosis or other risk factors for liver disease. The disease management intervention may lower the risk of liver cancer through exercise, diet, and health promoting lifestyle changes.